JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 30, 2007; DOI: 10.1124/jpet.107.120097


0022-3565/07/3223-1051-1058$20.00
JPET 322:1051-1058, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jpet.107.120097v1
322/3/1051    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jung, K.-H.
Right arrow Articles by Roh, J.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jung, K.-H.
Right arrow Articles by Roh, J.-K.

NEUROPHARMACOLOGY

Blockade of AT1 Receptor Reduces Apoptosis, Inflammation, and Oxidative Stress in Normotensive Rats with Intracerebral HemorrhageFormula

Keun-Hwa Jung, Kon Chu, Soon-Tae Lee, Se-Jeong Kim, Eun-Cheol Song, Eun-Hee Kim, Dong-Kyu Park, Dong-In Sinn, Jeong-Min Kim, Manho Kim, and Jae-Kyu Roh

Stroke and Neural Stem Cell Laboratory, Department of Neurology, Clinical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea (K.-H.J., K.C., S.-T.L., S.-J.K., E.-C.S., E.-H.K., D.-K.P., D.-I.S., J.-M.K., M.K., J.-K.R.); Program in Neuroscience, Neuroscience Research Institute of Seoul National University Medical Research Center, Seoul National University, Seoul, Republic of Korea (K.-H.J., K.C., S.-T.L., D.-I.S., M.K., J.-K.R.); and Division of Epidemic Intelligence Service, Korea Center for Disease Control and Prevention, Seoul, Republic of Korea (K.-H.J.)

Angiotensin II exerts its central nervous system effects primarily via its receptors AT1 and AT2, and it participates in the pathogenesis of ischemia via AT1. The selective AT1 receptor blocker (ARB) is used in the hypertension treatment, and it exerts a variety of pleiotropic effects, including antioxidative, antiapoptotic, and anti-inflammatory effects. In this study, we investigated the therapeutic effect of the ARB telmisartan in experimental intracerebral hemorrhage (ICH) in normotensive rats. ICH was induced via the collagenase infusion or autologous blood injection. Either telmisartan at 30 mg/kg/dose or phosphate-buffered saline was orally administered 2 h after ICH induction. We evaluated hemorrhage volume, brain water content, and functional recovery, and we performed the histological analysis for terminal deoxynucleotidyl transferase dUTP nick-end labeling, leukocyte infiltration, and microglia activation. A variety of intracellular signals, in terms of oxidative stress, apoptotic molecules, and inflammatory mediators, were also measured. Telmisartan reduced hemorrhage volume, brain edema, and inflammatory or apoptotic cells in the perihematomal area. Telmisartan was noted to induce the expression of endothelial nitric-oxide synthase and peroxisome proliferator-activated receptor {gamma} and decrease oxidative stress, apoptotic signal, tumor necrosis factor-{alpha}, and cyclooxygenase-2 expression. The telmisartan-treated rats exhibited less pronounced neurological deficits and recovered better. Thus, telmisartan seems to offer neural protection, including antiapoptosis, anti-inflammatory, and antioxidant benefits in the intracerebral hemorrhage rat model.


Received January 18, 2007; accepted May 29, 2007.

Address correspondence to: Dr. Jae-Kyu Roh, Department of Neurology, Seoul National University Hospital, 28, Yongon-Dong, Chongro-Gu, Seoul, 110-744, Republic of Korea. E-mail: rohjk{at}snu.ac.kr




This article has been cited by other articles:


Home page
HypertensionHome page
F. Scalera, J. Martens-Lobenhoffer, A. Bukowska, U. Lendeckel, M. Tager, and S. M. Bode-Boger
Effect of Telmisartan on Nitric Oxide-Asymmetrical Dimethylarginine System: Role of Angiotensin II Type 1 Receptor and Peroxisome Proliferator Activated Receptor {gamma} Signaling During Endothelial Aging
Hypertension, March 1, 2008; 51(3): 696 - 703.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.